Results 231 to 240 of about 67,878 (296)

Design and Biological Evaluation of Palladium(II)-Phosphine-Benzimidazole Complexes as Dual Antioxidant and Antiangiogenic Agents. [PDF]

ACS Omega
Kiyan HT, Ögüt K, Soyer P, Ünver H, Erol Kutucu D.   +4 more
europepmc   +1 more source

Anti-angiogenesis in human lymphomas. New insights. [PDF]

Front Oncol
Ribatti D, Tamma R, Ingravallo G, Specchia G.   +3 more
europepmc   +1 more source

A review of thalidomide and digestive system related diseases. [PDF]

Front Oncol
Xi Z, Jie W, Long Z, Shasha S.
europepmc   +1 more source

Optimising multiple myeloma therapy in resource-limited settings: current perspectives and challenges. [PDF]

Ecancermedicalscience
Tiwari B, Sapkota S.
europepmc   +1 more source

The Effect of Thalidomide on Bleomycin-Induced Pulmonary Fibrosis in Rats

, 2009
Shahram Rafieian, Alavi Seyed Ali, Mirkheshti Noushin, Atefeh Sadeghizadeh   +3 more
openalex   +1 more source

Bevacizumab for refractory gastrointestinal angiodysplasia: a case report and literature review. [PDF]

Eur J Gastroenterol Hepatol
Furumaya A, Goltstein LCMJ, Tushuizen ME, Klemt-Kropp M.   +3 more
europepmc   +1 more source

Secondary musculoskeletal disability and rehabilitation aspects in adults with thalidomide embryopathy: A narrative review. [PDF]

Intractable Rare Dis Res
Haga N, Fujitani J, Kobayashi T, Fujiwara S, Tsujimura H, Shirahoshi S, Tanabe A.   +6 more
europepmc   +1 more source

Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma [PDF]

, 2017
Chasse, E., Gay, B., Pichert, G., Taverna, C., Trojan, A.   +4 more
core  

Thalidomide in Small Cell Lung Cancer: Wrong Drug or Wrong Disease? [PDF]

, 2017
Peters, Solange, Rüegg, Curzio
core